1. Cell Cycle/DNA Damage PI3K/Akt/mTOR
  2. DNA-PK
  3. DNA-PK-IN-8

DNA-PK-IN-8 is a highly potent, selective and orally active DNA-dependent protein kinase (DNA-PK) inhibitor with an IC50 value of 0.8 nM. DNA-PK-IN-8 exhibits synergistic antiproliferative activity against a series of cancer cell lines and significantly suppresses HL-60 tumor growth, when using in combination with Doxorubicin.

For research use only. We do not sell to patients.

DNA-PK-IN-8 Chemical Structure

DNA-PK-IN-8 Chemical Structure

CAS No. : 2823369-81-7

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

DNA-PK-IN-8 is a highly potent, selective and orally active DNA-dependent protein kinase (DNA-PK) inhibitor with an IC50 value of 0.8 nM. DNA-PK-IN-8 exhibits synergistic antiproliferative activity against a series of cancer cell lines and significantly suppresses HL-60 tumor growth, when using in combination with Doxorubicin[1].

IC50 & Target

IC50: 0.8 nM (DNA-PK)[1]

In Vitro

DNA-PK-IN-8 (compound DK1) decreases the expression levels of γH2A.X in a concentration-dependent manner in HCT-116 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Immunofluorescence

Cell Line: HCT-116 (treated with Bleomycin for 6 hours)[1]
Concentration: 1, 5, and 10 μM
Incubation Time: 6 hours
Result: Decreased the expression levels of γH2A.X in a concentration-dependent manner.
In Vivo

DNA-PK-IN-8 (100 mg/kg; PO; QD for 16 days) significantly suppresses HL-60 tumor growth when co-administrating with Doxorubicin[1].
DNA-PK-IN-8 (5 mg/kg; PO; single dosage) exhibits reasonable pharmacokinetic properties in vitro and in vivo as an oral drug candidate[1].
Pharmacokinetic Parameters of DNA-PK-IN-8 in Sprague-Dawley rats[1].

PO (5 mg/kg)
Tmax (h) 0.42 ± 0.11
t1/2 (h) 1.59 ± 0.26
Cmax (ng/mL) 810 ± 122.32
AUC0-∞ (ng/mL·h) 3598.7 ± 769.81
MRT0-∞ (h) 2.29 ± 0.18

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: HL-60 tumor-bearing nude mice model[1]
Dosage: 100 mg/kg
Administration: PO; QD for 16 days
Result: Led to significant tumor-suppressing effects with TGI values of 52.4% and 62.4% for tumor weight and tumor volume, respectively, when co-administrated with Doxorubicin.
Animal Model: Sprague-Dawley rats[1]
Dosage: 5 mg/kg
Administration: PO; single dosage (Pharmacokinetic Analysis)
Result: Exhibited reasonable pharmacokinetic properties in vitro and in vivo as an oral drug candidate.
Molecular Weight

394.43

Formula

C19H22N8O2

CAS No.
SMILES

CC1=CC2=NC=NN2C=C1NC3=NC=C4C(N(CC(N4C)=O)C5CCOCC5)=N3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

DNA-PK-IN-8 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
DNA-PK-IN-8
Cat. No.:
HY-146565
Quantity:
MCE Japan Authorized Agent: